A Multiplex Assay to Assess Activated p300/CBP in Circulating Prostate Tumor Cells
July 24, 2023
PRESS RELEASE: On July 20, 2023, a new research paper was published in Oncotarget, entitled, “Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells.” continue reading »